These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11930055)

  • 1. CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US.
    Shibata T; Iimuro Y; Yamamoto Y; Ikai I; Itoh K; Maetani Y; Ametani F; Kubo T; Konishi J
    Radiology; 2002 Apr; 223(1):115-20. PubMed ID: 11930055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder.
    Huang H; Liang P; Yu XL; Cheng ZG; Han ZY; Yu J; Liu FY
    Int J Hyperthermia; 2015 Feb; 31(1):40-7. PubMed ID: 25766386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection.
    Seror O; N'Kontchou G; Haddar D; Dordea M; Ajavon Y; Ganne N; Trinchet JC; Beaugrand M; Sellier N
    Radiology; 2005 Jan; 234(1):299-309. PubMed ID: 15564388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
    Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
    J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients.
    Giorgio A; Tarantino L; Mariniello N; de Stefano G; Perrotta A; Aloisio V; Voza A; Finizia L; Alaia A; Del Viscovo L
    Eur J Ultrasound; 1998 Dec; 8(3):201-6. PubMed ID: 9971904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
    Castroagudín JF; Delgado M; Villanueva A; Bustamante M; Martínez J; Otero E; Tomé S; Martínez SM; Segade FR; Conde R; Dominguez-Muñoz E; Varo E
    Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
    Bartolozzi C; Lencioni R; Armillotta N
    Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nonsurgical treatments for hepatocellular carcinoma in the caudate lobe.
    Shibata T; Maetani Y; Ametani F; Kubo T; Itoh K; Konishi J
    Cardiovasc Intervent Radiol; 2002; 25(3):186-92. PubMed ID: 12058213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2T open MR system.
    Kim YJ; Raman SS; Yu NC; Lu DS
    J Magn Reson Imaging; 2005 Oct; 22(4):566-71. PubMed ID: 16161074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection.
    Yamamoto J; Okada S; Shimada K; Okusaka T; Yamasaki S; Ueno H; Kosuge T
    Hepatology; 2001 Oct; 34(4 Pt 1):707-13. PubMed ID: 11584366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.
    Giorgio A; Tarantino L; de Stefano G; Perrotta A; Aloisio V; del Viscovo L; Alaia A; Lettieri G
    Eur J Ultrasound; 2000 Dec; 12(2):145-54. PubMed ID: 11118922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases].
    Dalla Palma L; Pozzi Mucelli R; Sponza M; Bartolozzi C; Lencioni R; Florio F; De Santis M; Gandini G; Matricardi L; Rossi C; Simonetti G; Pocek M
    Radiol Med; 1997; 94(1-2):30-6. PubMed ID: 9424647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US.
    Bartolozzi C; Lencioni R; Ricci P; Paolicchi A; Rossi P; Passariello R
    Radiology; 1998 Nov; 209(2):387-93. PubMed ID: 9807563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.